SwePub
Sök i LIBRIS databas

  Utökad sökning

(swepub) lar1:(oru) pers:(Tysk Curt) conttype:(refereed)
 

Sökning: (swepub) lar1:(oru) pers:(Tysk Curt) conttype:(refereed) > Low-dose budesonide...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00008963naa a2200805 4500
001oai:DiVA.org:oru-47352
003SwePub
008160108s2016 | |||||||||||000 ||eng|
009oai:lup.lub.lu.se:ce882173-09fc-4163-9b30-2d40f1f2a5ce
009oai:prod.swepub.kib.ki.se:132594617
009oai:DiVA.org:liu-112705
009oai:DiVA.org:uu-274273
024a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-473522 URI
024a https://doi.org/10.1136/gutjnl-2014-3083632 DOI
024a https://lup.lub.lu.se/record/48159492 URI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1325946172 URI
024a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1127052 URI
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2742732 URI
040 a (SwePub)orud (SwePub)lud (SwePub)kid (SwePub)liud (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Münch, Andreasu Östergötlands Läns Landsting,Linköpings universitet,Avdelningen för inflammationsmedicin,Hälsouniversitetet,Magtarmmedicinska kliniken,Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Gastroenterol & Hepatol, S-58185 Linkoping, Sweden.4 aut0 (Swepub:liu)andsa76
2451 0a Low-dose budesonide for maintenance of clinical remission in collagenous colitis :b a randomised, placebo-controlled, 12-month trial
264 c 2014-11-25
264 1b BMJ Publishing Group,c 2016
338 a print2 rdacarrier
500 a Funding Agency:Dr Falk Pharma GmbH, Freiburg, Germany 
500 a Funding agencies: Dr Falk Pharma GmbH, Freiburg, Germany
520 a Objective: This 1-year study aimed to assess low-dose budesonide therapy for maintenance of clinical remission in patients with collagenous colitis.Design: A prospective, randomised, placebo-controlled study beginning with an 8-week open-label induction phase in which patients with histologically confirmed active collagenous colitis received budesonide (Budenofalk, 9 mg/day initially, tapered to 4.5 mg/day), after which 92 patients in clinical remission were randomised to budesonide (mean dose 4.5 mg/day; Budenofalk 3 mg capsules, two or one capsule on alternate days) or placebo in a 12-month double-blind phase with 6 months treatment-free follow-up. Primary endpoint was clinical remission throughout the double-blind phase.Results: Clinical remission during open-label treatment was achieved by 84.5% (93/110 patients). The median time to remission was 10.5 days (95% CI (9.0 to 14.0 days)). The maintenance of clinical remission at 1 year was achieved by 61.4% (27/44 patients) in the budesonide group versus 16.7% (8/48 patients) receiving placebo (treatment difference 44.5% in favour of budesonide; 95% CI (26.9% to 62.7%), p<0.001). Health-related quality of life was maintained during the 12-month double-blind phase in budesonide-treated patients. During treatment-free follow-up, 82.1% (23/28 patients) formerly receiving budesonide relapsed after study drug discontinuation. Low-dose budesonide over 1 year resulted in few suspected adverse drug reactions (7/44 patients), all non-serious.Conclusions: Budesonide at a mean dose of 4.5 mg/day maintained clinical remission for at least 1 year in the majority of patients with collagenous colitis and preserved health-related quality of life without safety concerns. Treatment extension with low-dose budesonide beyond 1 year may be beneficial given the high relapse rate after budesonide discontinuation.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Gastroenterologi0 (SwePub)302132 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Gastroenterology and Hepatology0 (SwePub)302132 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicin0 (SwePub)3022 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicine0 (SwePub)3022 hsv//eng
700a Bohr, Johan,d 1957-u Region Örebro län,Department of Gastroenterology, Örebro University Hospital, Örebro, Sweden,Örebro University Hospital, and School of Health and Medical Sciences, Örebro University, Sweden,Univ Orebro, Orebro Univ Hosp, Dept Gastroenterol, SE-70182 Orebro, Sweden.;Univ Orebro, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden.4 aut0 (Swepub:oru)jbr
700a Miehlke, Stephanu Centre for Digestive Disease, Hamburg, Germany,Ctr Digest Dis, Hamburg, Germany.4 aut
700a Benoni, Ceciliau Lund University,Lunds universitet,Anestesiologi och intensivvård,Forskargrupper vid Lunds universitet,Anaesthesiology and Intensive Care Medicine,Lund University Research Groups,University Hospital, Malmö, Sweden,Univ Hosp, Dept Gastroenterol, Malmo, Sweden.4 aut0 (Swepub:lu)medf-cbe
700a Olesen, Martinu Department of Pathology, University Hospital, Malmö, Sweden,Univ Hosp, Dept Pathol, Malmo, Sweden.4 aut
700a Öst, Åkeu Department of Pathology and Cytology, Aleris Medilab, Täby, Sweden,Aleris Medilab, Dept Pathol & Cytol, Taby, Sweden.4 aut
700a Strandberg, Larsu Regional Hospital, Falun, Sweden,Reg Hosp, Falun, Sweden.4 aut
700a Hellström, Per M.u Uppsala universitet,Gastroenterologi/hepatologi4 aut0 (Swepub:uu)perhe742
700a Hertervig, Eriku Lund University,Lunds universitet,Medicin, Lund,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medicine, Lund,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,University Hospital, Lund, Sweden,Univ Lund Hosp, Dept Gastroenterol, S-22185 Lund, Sweden.4 aut0 (Swepub:lu)med-ehe
700a Armerding, Peteru Gastroenterology, Private Practice, Berlin, Germany4 aut
700a Stehlik, Jiriu Department of Gastroenterology, Regional Hospital, Usti nad Labem, Czech Republic,Reg Hosp, Dept Gastroenterol, Usti Nad Labem, Czech Republic.4 aut
700a Lindberg, Gregeru Karolinska Institutet,Karolinska University Hospital Huddinge, Stockholm, Sweden,Karolinska Univ Hosp Huddinge, Ctr Digest Dis, Stockholm, Sweden.4 aut
700a Björk, Janu Karolinska Institutet,Karolinska University Hospital Solna, Stockholm, Sweden,Karolinska Univ Hosp Solna, Ctr Digest Dis, Stockholm, Sweden.4 aut
700a Lapidus, Annikau Department of Gastroenterology, Ersta Hospital, Stockholm, Sweden,Ersta Hosp, Dept Gastroenterol, Stockholm, Sweden.4 aut
700a Löfberg, Robertu IBD Unit, Department of Gastroenterology, Sophiahemmet, Stockholm, Sweden,Sophiahemmet, Dept Gastroenterol, IBD Unit, Stockholm, Sweden.4 aut
700a Bonderup, Oleu Department of Gastroenterology, Regional Hospital, Silkeborg, Denmark,Reg Hosp, Dept Gastroenterol, Silkeborg, Denmark.4 aut
700a Avnström, Sörenu Department of Gastroenterology, Amager Hospital, Copenhagen, Denmark,Amager Hosp, Dept Gastroenterol, Copenhagen, Denmark.4 aut
700a Rössle, Martinu Gastroenterology, Private Practice, Freiburg, Germany4 aut
700a Dilger, Karinu Dr Falk, Pharma GmBH, Freiburg, Germany4 aut
700a Mueller, Ralphu Dr Falk, Pharma GmBH, Freiburg, Germany4 aut
700a Greinwald, Rolandu Dr Falk, Pharma GmBH, Freiburg, Germany4 aut
700a Tysk, Curt,d 1949-u Region Örebro län,Department of Gastroenterology, Örebro University Hospital, Örebro, Sweden,Örebro University Hospital, and School of Health and Medical Sciences, Örebro University, Sweden,Univ Orebro, Orebro Univ Hosp, Dept Gastroenterol, SE-70182 Orebro, Sweden.;Univ Orebro, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden.4 aut0 (Swepub:oru)ctk
700a Ström, Magnusu Linköpings universitet,Östergötlands Läns Landsting,Magtarmmedicinska kliniken,Avdelningen för neuro- och inflammationsvetenskap,Medicinska fakulteten,Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Gastroenterol & Hepatol, S-58185 Linkoping, Sweden.4 aut0 (Swepub:liu)magst47
710a Linköpings universitetb Avdelningen för inflammationsmedicin4 org
773t Gutd : BMJ Publishing Groupg 65:1, s. 47-56q 65:1<47-56x 0017-5749x 1468-3288
856u https://doi.org/10.1136/gutjnl-2014-308363y Fulltext
856u https://gut.bmj.com/content/gutjnl/65/1/47.full.pdf
856u http://www.ncbi.nlm.nih.gov/pubmed/25425655?dopt=Abstracty FULLTEXT
856u http://dx.doi.org/10.1136/gutjnl-2014-308363y FULLTEXT
856u https://uu.diva-portal.org/smash/get/diva2:912697/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-47352
8564 8u https://doi.org/10.1136/gutjnl-2014-308363
8564 8u https://lup.lub.lu.se/record/4815949
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:132594617
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-112705
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-274273

Hitta via bibliotek

  • Gut (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy